Literature DB >> 9118909

Modeling marrow damage from response data: evolution from radiation biology to benzene toxicity.

D T Jones1, M D Morris, J S Hasan.   

Abstract

Consensus principles from radiation biology were used to describe a generic set of nonlinear, first-order differential equations for modeling toxicity-induced compensatory cell kinetics in terms of sublethal injury, repair, direct killing, killing of cells with unrepaired sublethal injury, and repopulation. This cellular model was linked to a probit model of hematopoietic mortality that describes death from infection and/or hemorrhage between 5 and 30 days. Mortality data from 27 experiments with 851 dose-response groups, in which doses were protracted by rate and/or fractionation, were used to simultaneously estimate all rate constants by maximum-likelihood methods. Data used represented 18,940 test animals: 12,827 mice, 2925 rats, 1676 sheep, 829 swine, 479 dogs, and 204 burros. Although a long-term, repopulating hematopoietic stem cell is ancestral to all lineages needed to restore normal homeostasis, the dose-response data from the protracted irradiations indicate clearly that the particular lineage that is critical to hematopoietic recovery does not resemble stemlike cells with regard to radiosensitivity and repopulation rates. Instead, the weakest link in the chain of hematopoiesis was found to have an intrinsic radioresistance equal to or greater than stromal cells and to repopulate at the same rates. Model validation has been achieved by predicting the LD50 and/or fractional group mortality in 38 protracted-dose experiments (rats and mice) that were not used in fitting of model coefficients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9118909      PMCID: PMC1469732          DOI: 10.1289/ehp.961041293

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  27 in total

1.  Acute toxicity of benzene inhalation to hemopoietic precursor cells.

Authors:  E M Uyeki; A E Ashkar; D W Shoeman; T U Bisel
Journal:  Toxicol Appl Pharmacol       Date:  1977-04       Impact factor: 4.219

2.  The effect of exposure rate on animal lethality and spleen colony cell survival.

Authors:  E A Puro; G M Clark
Journal:  Radiat Res       Date:  1972-10       Impact factor: 2.841

3.  Effects of short-term benzene administration on bone marrow cell cycle kinetics in the rat.

Authors:  R D Irons; H Heck; B J Moore; K A Muirhead
Journal:  Toxicol Appl Pharmacol       Date:  1979-12       Impact factor: 4.219

4.  A cell-kinetics model for radiation-induced myelopoiesis.

Authors:  T D Jones; M D Morris; R W Young; R A Kehlet
Journal:  Exp Hematol       Date:  1993-06       Impact factor: 3.084

5.  Acute and chronic dose/response effects of inhaled benzene on multipotential hematopoietic stem (CFU-S) and granulocyte/macrophage progenitor (GM-CFU-C) cells in CD-1 mice.

Authors:  J D Green; C A Snyder; J LoBue; B D Goldstein; R E Albert
Journal:  Toxicol Appl Pharmacol       Date:  1981-05       Impact factor: 4.219

6.  The detection of in vivo hematotoxicity of benzene by in vitro liquid bone marrow cultures.

Authors:  K Harigaya; M E Miller; E P Cronkite; R T Drew
Journal:  Toxicol Appl Pharmacol       Date:  1981-09-15       Impact factor: 4.219

7.  Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice.

Authors:  A Tunek; T Olofsson; M Berlin
Journal:  Toxicol Appl Pharmacol       Date:  1981-06-15       Impact factor: 4.219

8.  The importance of pluripotential stem cells in benzene toxicity.

Authors:  D P Gill; V K Jenkins; R R Kempen; S Ellis
Journal:  Toxicology       Date:  1980       Impact factor: 4.221

9.  Origin of human bone marrow fibroblasts.

Authors:  D W Golde; W G Hocking; S G Quan; R S Sparkes; R P Gale
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

Review 10.  Chemically induced leukemia in humans.

Authors:  R H Adamson; S M Seiber
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.